199590-69-7

Basic information

• Product Name: Benzenesulfonamide, 2-fluoro-4-methyl- (9CI)
• Synonyms: Benzenesulfonamide, 2-fluoro-4-methyl- (9CI);2-Fluoro-4-methylbenzenesulphonamide
• CAS NO: 199590-69-7
• Molecular Formula: C₇H₈FNO₂S
• Molecular Weight: 189.2073232
• Product Categories: SULFONAMIDE
• Mol File: 199590-69-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 324.4±52.0 °C(Predicted)
• Appearance: /
• Density: 1.362±0.06 g/cm3(Predicted)
• PKA: 9.82±0.60(Predicted)
• CAS DataBase Reference: Benzenesulfonamide, 2-fluoro-4-methyl- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, 2-fluoro-4-methyl- (9CI)(199590-69-7)
• EPA Substance Registry System: Benzenesulfonamide, 2-fluoro-4-methyl- (9CI)(199590-69-7)

Safety Data

• Hazardous Substances Data: 199590-69-7(Hazardous Substances Data)

Upstream product

• 518070-29-6 2-fluoro-4-methylbenzene-1-sulfonyl chloride 
• 452-80-2 2-fluoro-4-methylaniline 

Downstream Products

• 1204573-70-5 2-(cyclopropylamino)-4-methylbenzenesulfonamide 

Relevant articles and documents

FLUORO-CONTAINING COMPOUNDS, USE AND PREPARATION THEREOF

The present teachings relate to a fluoro-containing compound, a composition thereof, a method of using the compound or the composition in treating a disease, and a method of preparing the compound. In a particular example, the compound is chosen from Form

Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them

Compounds of formula (I): wherein: RCy represents an unsubstituted or substituted cycloalkyl group or cycloalkylalkyl group,R1, R2, R3 and R4, which may be the same or different, each represent a hydrogen or halogen atom or a nitro group; a cyano group; a hydroxy group; an alkoxy group; an alkyl group; an unsubstituted or substituted amino group; a carboxy group; an alkoxycarbonyl group; an aryloxycarbonyl group; an unsubstituted or substituted aminocarbonyl group. Medicinal products containing the same which are useful in treating or preventing conditions treatable by an AMPA receptor modulator.